Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Laimer
Christine Prodinger

Showing results (111-120 of 112) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 112 results.
JCI Insight|October 19, 2021
Clinical trial of ABCB5+ mesenchymal stem cells for recessive dystrophic epidermolysis bullosaDimitra Kiritsi, Kathrin Dieter, Elke Niebergall-Roth, et al.
Journal of the American Academy of Dermatology|July 19, 2020
Multidisciplinary care of epidermolysis bullosa during the COVID-19 pandemic-Consensus: Recommendations by an international panel of expertsDedee F Murrell, Anne W Lucky, Julio C Salas-Alanis, et al.
Pageof 12

Showing results (111-120 of 112) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 112 results.
JCI Insight|October 19, 2021
Clinical trial of ABCB5+ mesenchymal stem cells for recessive dystrophic epidermolysis bullosaDimitra Kiritsi, Kathrin Dieter, Elke Niebergall-Roth, et al.
Journal of the American Academy of Dermatology|July 19, 2020
Multidisciplinary care of epidermolysis bullosa during the COVID-19 pandemic-Consensus: Recommendations by an international panel of expertsDedee F Murrell, Anne W Lucky, Julio C Salas-Alanis, et al.
Pageof 12